Ravi Anand
Anand Pharma Consulting, St. Moritz, Switzerland
In presentations
Saturday, June 27, 02:58 PM – 03:04 PM
Translating glutamate modulation into clinical advances for patients with treatment-resistant schizophrenia: challenges and updates from the ENIGMA-TRS phase 3 program
Speaker: Ravi Anand (Anand Pharma Consulting, Pharma R&D, St. Moritz, Switzerland)
Monday, June 29, 12:27 PM – 12:33 PM
Targeting negative and cognitive symptoms in schizophrenia: discussion of novel preclinical and clinical findings with evenamide
Speaker: Ravi Anand (Anand Pharma Consulting, Pharma R&D, St. Moritz, Switzerland)